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between general practitioners and patients
with acute respiratory infections
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Abstract
Background: Little research has examined whether shared decision making (SDM) occurs in consultations for acute
respiratory infections (ARIs), including what, and how, antibiotic benefits and harms are discussed. We aimed to
analyse the extent and nature of SDM in consultations between GPs and patients with ARIs, and explore
communication with and without the use of patient decision aids.
Methods: This was an observational study in Australian general practices, nested within a cluster randomised trial
of decision aids (for acute otitis media [AOM], sore throat, acute bronchitis) designed for general practitioners (GPs)
to use with patients, compared with usual care (no decision aids). Audio-recordings of consultations of a
convenience sample of consenting patients seeing a GP for an ARI were independently analysed by two raters
using the OPTION-12 (observing patient involvement in decision making) scale (maximum score of 100) and 5
items (about communicating evidence) from the Assessing Communication about Evidence and Patient Preferences
(ACEPP) tool (maximum score of 5). Patients also self-completed a questionnaire post-consultation that contained
items from CollaboRATE-5 (perceptions of involvement in the decision-making process), a decisional conflict scale,
and a decision self-efficacy scale. Descriptive statistics were calculated for each measure.
Results: Thirty-six consultations, involving 13 GPs, were recorded (20 for bronchitis, 10 sore throat, 6 AOM). The
mean (SD) total OPTION-12 score was 29.4 (12.5; range 4–54), with item 12 (need to review decision) the highest
(mean = 3) and item 10 (eliciting patients’ preferred level of decision-making involvement) the lowest (mean = 0.1).
The mean (SD) total ACEPP score was 2 (1.6), with the item about discussing benefits scoring highest. In
consultations where a decision aid was used (15, 42%), compared to the 21 usual care consultations, mean
observer-assessed SDM scores (OPTION-12, ACEPP scores) were higher and antibiotic harms mentioned in all
(compared to only 1) consultations. Patients generally reported high decision involvement and self-efficacy, and low
decisional conflict.
Conclusions: The extent of observer-assessed SDM between GPs and patients with ARIs was generally low.
Balanced discussion of antibiotic benefits and harms occurred more often when decision aids were used.
Keywords: Decision making, General practice, Respiratory tract infections, Decision support techniques, Physician-
patient relations
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Background
One of the main causes of increased antibiotic resistance
is high levels of antibiotic use, with approximately 80%
of antibiotic use occurring in the community [1]. Within
primary care, acute respiratory infections (ARIs) are one
of the most common reasons for an antibiotic prescrip-
tion, even though antibiotics provide only small benefit
and can cause harms [2–5].
General practitioners’ (GP) antibiotic prescribing behav-
iours are influenced by many factors, including diagnostic
uncertainty, perceived patient pressure for antibiotics, and
the need to maintain a good relationship with patients [6–
9]. Many patients believe that antibiotics resolve symp-
toms, are necessary, and have no harms [10]. These beliefs
contribute to some patients expecting, and sometimes
requesting, antibiotics [10–12].
Shared decision making (SDM) is a process that in-
volves clinicians and patients jointly participating in
making a health decision, after having discussed the op-
tions and the benefits and harms of each option, and
considered the patient’s values, preferences and circum-
stances [13–15]. For most ARIs, the choice about
whether to treat with antibiotics, or not, is nearly at
equipoise, with the benefits closely balanced by the
harms. This makes consultations for ARIs ideally suited
for SDM. When deciding about antibiotic use for ARIs,
most patients want more involvement in the
decision-making process and more opportunity to weigh
up the benefits and harms of the options [16, 17]. A re-
cent systematic review found that interventions to facili-
tate SDM reduced antibiotic prescribing for ARIs in
primary care, compared with usual care, from 47 to 29%
(risk ratio of 0.61; 95% confidence interval 0.55 to 0.68)
[18]. However, there has been little exploration of the
prevalence and nature of SDM in GP consultations for
ARIs, including whether and how any patient decision
aids may be used to facilitate SDM.
In a sample of consultations (where some GPs had
been provided with ARI decision aids), we aimed to: 1)
analyse the extent and nature of SDM in consultations
between GPs and patients with ARIs, including if and
how antibiotic benefits and harms are discussed; 2) ex-
plore the use of patient decision aids in ARI consulta-
tions and the communication of antibiotic benefits and
harms with and without decision aids; and 3) explore pa-
tients’ perspectives of the decision-making process.
Methods
Design
This was an observational study that ran in parallel to
an ongoing cluster randomised trial of three decision
aids (for acute otitis media [AOM], acute sore throat,
and acute bronchitis) and a brief GP SDM training
package [19] (Australian New Zealand Clinical Trials
Registry (ANZCTR) number: ACTRN12616000644460).
Participants and setting
For the trial, general practices were recruited from
established GP research networks, primarily in southeast
Queensland, Australia. Practices whose GPs had already
consented for the trial or its pilot were invited to partici-
pate in, and provide written consent for, this additional
study during 2017. Practices were not eligible if they had
participated in any other study where the main intention
was to reduce antibiotic prescribing for ARIs. Patients
were eligible to participate if they met the following cri-
teria: 1) adult or parent of a child consulting a GP with
one of three ARIs (AOM, acute sore throat, acute bron-
chitis) for the first time for that illness episode; 2) able
to understand and read English; and 3) provided written
informed consent.
Some GPs (in practices that had been randomised to
the trial’s intervention group or had piloted the interven-
tion) had previously been provided with: 1) three deci-
sion aids (one each for AOM, acute sore throat, and
acute bronchitis), in printed form (single A4 page,
double-sided and laminated) and in PDF (Add-
itional files 1, 2 and 3); and 2) a USB-drive containing a
15-min video-based SDM training package that ex-
plained what SDM is, its use in ARI consultations, and a
consultation demonstrating use of one of the decision
aids. These GPs were given the intervention package and
encouraged to use the aids during consultations with pa-
tients with ARIs whenever they felt it was appropriate.
No further instruction or encouragement to use the aids
or SDM strategies occurred. The GPs in practices rando-
mised to the control group did not receive the training
package or decision aids and continued providing their
usual care.
Procedure
The exact procedure for recruiting patients varied ac-
cording to each practice’s preference. On recruitment
days, at some practices, one of us (MB) approached only
patients who were waiting to see the GPs who were par-
ticipating. In other practices, all waiting patients were
approached and asked if they were waiting to see one of
the participating GPs (GP names were listed). If so, we
proceeded with recruitment. Patient eligibility was deter-
mined by asking the patients if they were suffering from
one of the following symptoms (sore throat, cough, ear
pain), and confirmed afterwards by the clinician. If the
patient was diagnosed as having an illness other than an
eligible ARI, the recording was deleted. After written in-
formed consent was provided, an audio-recording device
was handed to the GP who began recording just before
the patient entered their consulting room. After patients
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left the room, they were given a short questionnaire (<
5 min) to complete. It contained basic demographic
questions and items from tools to measure their per-
spectives of involvement in the decision-making process,
decisional conflict, and confidence in decision-making
(see section below on patients’ perspectives).
Outcome measures
The extent of SDM (observer-assessed)
Each consultation recording was analysed, by listening
to the audio-recordings, by two independent raters using
two measures. One measure was the 12-item Observing
Patient Involvement (OPTION-12) scale, which has
good discriminative validity, concurrent validity, and
interrater and intra-rater reliability [20, 21]. It contains
12 items scored on a five-point scale: (0) the behaviour
was not observed; (1) a minimal attempt is made; (2) the
behaviour is observed with a minimal skill level; (3) the
behaviour is executed to a good standard; and (4) the be-
haviour is executed to a high standard. Total scores were
re-scaled to 0–100. A second measure was 5 items (1
subscale) of the Assessing Communication about Evi-
dence and Patient Preferences (ACEPP) tool. This was
used as the OPTION scale does not specifically evaluate
communication of the quantitative benefits and harms
of the options. It has good reliability and has been used
previously to assess evidence communication in consul-
tations [22, 23]. The items rate clinicians’ performance
in describing the benefits/harms in terms of patient out-
comes, the likelihood of benefits/harms, and the evi-
dence source. Items were scored as: the behaviour was
not observed (0); behaviour was observed at a basic level
(0.5); or observed to an extended level (1).
To establish scoring reliability, three of us (MB, EG,
TH) independently rated an initial sample of recordings
and responses were discussed until agreement was
reached. Two of us (MB, EG) independently rated the
remainder. Any rating discrepancies were resolved by a
third person (TH). The two raters also extracted verba-
tim any mention of antibiotic benefits and harms.
Patients’ perspectives
Patients’ perceptions of their involvement in the
decision-making process were measured using the
CollaboRATE-5 scale (score range 0 to 5) [24, 25]. It
asks three questions about what occurred in the consult-
ation: 1) deliberation of the health issue, 2) exploration
of patient preferences, and 3) integration of patient pref-
erences [25]. The scale has demonstrated significant dis-
criminative validity, excellent intra-rater reliability and
concurrent validity with other measures of SDM [24].
Decisional conflict is a condition of uncertainty about
options involving trade-offs and potential for regret. It
was measured using the 10-item low literacy decisional
conflict scale [26]. In this study, patients’ feelings conflict
about whether they felt that their decision (using antibi-
otics or not) was the best for them was assessed. The
scale has good validity and reliability [26]. The
low-literacy version uses a question-and-answer format
with three response options (yes, no, unsure), with scor-
ing from 0 (low decisional conflict) to 100 (high deci-
sional conflict) [27].
Patients’ confidence in decision-making was measured
using four items from the decision self-efficacy scale
[28], which has high internal consistency [29]. Scoring of
each item is from 0 (not at all confident) to 100 (very
confident).
Data analysis
We calculated descriptive statistics (mean, standard de-
viation, range) for each outcome measure. Data were
analysed using IBM SPSS (version 23). Benefits and
harms of antibiotics mentioned were categorised into
similar groups, by description level as per ACEPP scor-
ing, and by whether a decision aid was used.
We present the results for the whole sample in line
with our original aims. However, to explore the impact
of decision aids, we also present the data separately for
those consultations in which a decision aid was used
and not used, along with mean differences and 95% con-
fidence intervals.
Results
Ten general practices (3 intervention, 5 control), involv-
ing 44 GPs, that had already consented to participate in
the main trial or piloting of the decision aids (2 prac-
tices) by the time that recruitment for this study com-
menced were invited to participate in this additional
study. Of these, 5 practices and 19 GPs provided con-
sent. During the recruitment period, 208 patients were
approached and 41 met the inclusion criteria. Of these,
36 patients provided consent for the recording and 25
also agreed to complete the questionnaire. The main
reason given for declining to complete the questionnaire
was insufficient time. We recorded 36 consultations, in-
volving 13 GPs - 20 were for acute bronchitis, 10 for
acute sore throat, and 6 for AOM. Patient, GP, and con-
sultation characteristics are presented in Table 1.
The extent of observer-assessed SDM
The mean (SD) total OPTION score was 29.4 (12.5;
range 4–54) (on a 100-point scale). The two highest
scoring items were Item 12 (clinician indicates the need
to review the decision) (mean = 3, SD = 1.5) and Item 4
(clinician lists ‘options’) (mean = 2.2, SD = 1.5). The two
lowest scoring items were Item 10 (clinician elicits pa-
tient’s preferred level of involvement in decision making)
(mean = 0.1, SD = 0.3), and Item 11 (clinician indicates
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the need for a decision making) (mean = 0.3, SD = 0.5)
(Fig. 1). The mean (SD) total ACEPP score was 2 (1.6)
(on a 5-point scale), with Item 1 (clinician describes the
treatment benefits) scoring the highest (mean = 0.6, SD
= 0.5) (Fig. 2).
In consultations in which a decision aid was used (n =
15), the mean (SD) total OPTION score was 38.8 (6.5),
compared to 22.7 (11.5) for those (n = 21) in which an
aid was not used - a mean difference of 16 (95% CI 9.4–
22.7). Similarly, the mean (SD) ACEPP score in consulta-
tions where an aid was used was 3.8 (0.5) which was
higher than those which did not 0.8 (0.8) - a mean dif-
ference of 3 (95% CI 2.6–3.5).
Discussion of antibiotic benefits and harms
Table 2 contains verbatim examples of how antibiotic
benefits and harms were presented within consultations,
categorised by level of description. The three most com-
monly discussed harms were diarrhoea, rash, and anti-
biotic resistance. In the 21 consultations that did not use a
decision aid, the potential harms were mentioned in only
1 consultation (with nausea mentioned). Conversely, in
the 15 consultations in which a decision aid was used, at
least one harm was mentioned in all of them. Two harms
were mentioned in 14 (93%) and 3 harms in 13 (87%) of
these consultations. When benefits were discussed, those
mentioned were: that antibiotics help patients’ symptoms
resolve faster; and reduce symptom severity, and the
chance of complications. Benefits and their likelihood
were explained in all 15 of the consultations where a deci-
sion aid was used. Where aids were not used, benefits
were mentioned in 7 (33%) of the 21 consultations, but
the likelihood of benefits described in only 1.
Patients’ perspectives of the consultation and decision-
making process
The mean (SD) CollaboRATE-5 score for all consulta-
tions was 3.8 (0.4), representing high perceived patient
involvement in the decision-making process. The mean
(SD) Decisional Conflict score was 3.2 (8), indicating a
low level of decisional conflict. Participants had high
confidence in the decision made, with a mean (SD) deci-
sion self-efficacy scale score of 95 (10). There were min-
imal differences between the scores of patients who had,
and had not, been presented with a decision aid during
the consultation (Table 3).
Discussion
Summary
Our analysis of consultations between GPs and patients
with ARIs found the extent of observer-assessed SDM
was generally low and the communication of antibiotic
benefits and harms was also often suboptimal. In consul-
tations in which patient decision aids were used, the dis-
cussion of antibiotic benefits and harms was more
frequent and more comprehensive. When decision aids
were not used, antibiotic harms were rarely mentioned,
and antibiotic resistance was never mentioned.
Strength and limitations
Strengths of our study include minimising any bias from
clinicians choosing which consultations to record as pa-
tient consent occurred before the consultations; two in-
dependent raters scoring the consultations; and
obtaining patients’ perspectives. Limitations include the
design (not a true randomised trial, although it is nested
within one), which might have exaggerated the effects of
the decision aids; the small number of consultations and
that they may be non-representative; and GPs’
self-selection to participate in this additional study,
which may have recruited those more confident and
competent in SDM. The presence of the audio recorder
in the consultation and the researcher in the waiting
room may have resulted in performance bias, such as
the Hawthorne effect, and inadvertently acted as a
prompt for GPs to attempt or improve SDM. Also,
Table 1 Characteristics of the GPs, patients, and consultations
Characteristic Na (%)
GP gender – female 11 (61)
Patients
Adults (Patient or parent) 18 (50)
Female 15 (83)
Age in years - median (min-max) 36 (18–77)
Children 18 (50)
Female 7 (39)
Age in years – median (min-max) 2 (0.8–15)
Condition
Acute bronchitis 20
Acute sore throat 10
Acute otitis media 6
Decision aid used in the consultation 15 (42)
Consultation duration (minutes) - median
(min-max)
9 (4–31)
Treatment decision (from analysis of
consultation recording)
Antibiotics 3
Delayed prescribing 7
No antibiotics 26
Treatment decision immediately
post-consultationb (as reported by patients)
Antibiotics 5
No antibiotics 20
aThis is the number of consultations, GPs, or patients
bNot all patients felt sufficiently decided to report their treatment decision
during the post-consultation interview
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results are limited to one country and clinicians partici-
pating may not be representative of those in other
settings.
Comparison with existing literature
We know of no other studies that have objectively ana-
lysed the extent of SDM in GP-patient consultations for
ARIs. Although a recent systematic review [18] of trials
whose interventions had aimed to increase SDM in ARI
consultations in primary care found that these interven-
tions decreased antibiotic prescribing, none of the 10 in-
cluded trials actually objectively measured whether SDM
improved as a result of the intervention.
Similarly low OPTION scores to those in this study
have been reported in previous studies in different set-
tings, such as outpatient cancer patients consulting their
physicians [30], patients with back pain consulting their
GPs [31], and patients consulting nutritionists about
dietary treatment [32]. In a systematic review of studies
that had used OPTION-12 to analyse consultations, OP-
TION Item 12 was one of the most consistently ob-
served behaviours [33], and Item 10 score was very low,
similar to our study.
Implications for practice and research
When decision aids were used the extent of SDM in-
creased, including a large improvement in the frequency
and quality of the conversation about antibiotic benefits
and harms. Having the options with their pros and cons
clearly listed in a decision aid may act as a reminder for
GPs to discuss them with patients. The better discussion
of antibiotic benefits and harms, including explaining
the size and/or likelihood of them, is also likely due to
the aids containing a very synthesized summary of the
evidence about antibiotic benefits and harms. GPs may
be unaware of the empirical benefits and harms data of
antibiotics for ARIs. While no studies have examined
GPs’ knowledge of antibiotic benefits and harms, a study
of paediatricians found they overestimate antibiotic ben-
efits for ARIs [34] and generally, clinicians tend to have
poor knowledge of treatment benefits and harms, over-
estimate benefits and underestimate harms [35].
Better benefit-harm perception by patients is neces-
sary for informed decision making, and randomised
trials have shown this improves when decision aids
are used [36]. In ARI consultations, improving patient
benefit-harm perception is particularly important
Fig. 2 Mean scores of ACEPP items about communication of benefits and harms
Fig. 1 Mean scores of OPTION 12 items
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Table 2 Verbatim examples of how the benefits and harms of antibiotics for ARIs were presented by GPs within the consultations,
grouped by level of description and whether a decision aid was used
Benefits of antibiotics Harms of antibiotics
Side effects Resistance
With
decision
aids
(n = 15)
Benefits mentioned in 15
(100%) of 15 consultations
Side-effects mentioned in 15 (100%) of 15
consultations
Resistance mentioned in 10 (67%) of 15
consultations
Mentioned to an extended
level* (15/15)
Examples:
Mentioned to an extended level (7/15)
Examples:
Mentioned to an extended level (5/10)
Examples:
GP D-2-6 “All the evidence shows if we
have somebody with middle ear infection
like what we have got here now…if you
don’t give any antibiotics the infection lasts
about 3.5 days in total. If you give antibiotics
it reduces that by 12 h. It can cut off about
12 h of the symptoms by giving antibiotics,
so giving antibiotics is of limited benefit” …
“so, if we look at 100 kids who don’t take
antibiotics, 84 will be better in 3 days. If we
give antibiotics there is an extra 5 kids who
would be better.”
GP B-1-2 “Most sore throats get better
somewhere between 2 and 7 days and that
is actually whether or not you get
antibiotics. Even if it is a bacterial infection
you get better without antibiotics. So the
treatment options are to take antibiotics or
to not take antibiotics … This is a graph that
shows you how long a sore throat would
last on average. So if you take antibiotics,
generally the sore throat would last about
2.6 days so just over 2 and a half days. If you
do not take antibiotics on average it will last
about 3.3 days, so that means it last about
16 h longer without the antibiotics.”
GP A-2-1 “What we are looking at over here
is what the potential complications maybe
with antibiotics. So people who do not take
antibiotics, 20 out of a 100 will have some
other problems associated with the illness.
Whether it be vomiting, diarrhoea or rash.
Whereas if we give you antibiotics, you are
more likely to have side effects or
complications. So 7 more people out of a
100 …will have these potential side effects
of these antibiotics. There are also other
harms with antibiotics which can be having
an allergic reaction, it can be the cost of
buying them, remembering to take them…”
GP A-5-2 “The other concern as well is
antibiotic resistance, meaning you know the
long term implications, all the good bacteria
in his system being exposed to antibiotics as
well they can develop some resistance, so
…[if] he got meningitis in the near time and
needs antibiotics, taking some will not work,
because of previous resistance”
GP B-1-2 “one of the problems that a lot of
the bacteria that we have had in the
community for years is getting stronger and
stronger and resisting the antibiotics that we
have got. So we are finding this is why this
shows here that only a few people finding
any benefit from taking the antibiotics
because there is more and more resistance
in the community… but we are finding
increasingly is that the more we use them
for infections that your body could probably
fight them by yourself, we are actually,
unfortunately, breeding bacteria that
become stronger and stronger… and
unfortunately at this point of time we have
bacteria that is resistant to everything we
have got and there is nothing new on the
horizon vastly different from what we have
got”
Mentioned to a basic level** (8/15)
Examples:
Mentioned to a basic level (5/10)
Examples:
GP D-2-4 “… the only problem is it
increases the number of people who get
rash, diarrhoea, another side effects because
of the antibiotics…”
GP A-3-1 “… but then you look at the side
effects and we have got all these people
who do not take antibiotics obviously no
side effects… and in the antibiotics you get
more side effects basically. So that’s each
one of these little dots is someone who gets
the side effect”
GP D-2-9 “but in the big picture we are
building on antibiotic resistance and you
know we are coming to time where these
things might not work for infections you got
them to do”
GP D-2-7 “… and then you worry about
antibiotic resistance and stuff like that”
Without
decision
aids
(n = 21)
Benefits mentioned in 7 (33%) of 21
consultations
Side-effects mentioned in 1 (5%) of 21
consultations
Resistance was not mentioned in any
consultations
Mentioned to an extended level (5/7)
Examples:
No extended level mentions
GP C-1-1 “The evidence is that middle ear
infection gets better 12 h to 24 h earlier if
you give antibiotics and the pain is better 12
to 24 h if you give antibiotics”
Mentioned to a basic level (2/7)
Examples:
Mentioned to a basic level (1/1)
Examples:
GP F-1-5 “…in which case antibiotics won’t
do anything to get you better quicker”
GP F-2-1 “And antibiotics would just give
him side effects and upset his tummy”
*Extended level: The clinician explains the benefits or harms of antibiotic treatment in a manner that is clear, with elaboration on the likelihood of these
occurring, **Basic level: The clinician lists at least some of the benefits or harms of antibiotic treatment
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because the evidence shows near-equipoise in the
benefits-harms balance, patients overestimate the ben-
efits of antibiotics for ARIs [17, 37], and they rarely
hear about the harms. Correcting these mispercep-
tions may break the cycle of patient expectations of
antibiotics as a driver of antibiotic prescribing.
Antibiotic resistance is different from the side-effects
that might typically be discussed by clinicians because it
is not obviously an immediate or personal consequence
for the individual patient. Many members of the public
have misunderstandings about what antibiotic resistance
is [38] and believe that it does not affect them [39].
However, it is a global problem that can affect anyone,
even if indirectly, and it needs confronting. Consulta-
tions in which antibiotics are being considered for com-
mon ARIs are an ideal time to discuss antibiotic
resistance as part of the benefit-harm trade-off of using
antibiotics because this is an area of very high consump-
tion. We found many missed opportunities for discus-
sions about this to occur. Even when resistance was
mentioned, discussion was usually brief and often not
clear. Clinicians’ misunderstandings of antibiotic resist-
ance have been reported in a systematic review [40].
Patients perceived that they had high involvement in
the decision, despite observer-assessed SDM scores
which were quite low. Reasons for this are not clear. Per-
haps patients have not experienced consultations in
which SDM was performed to a high level and they have
low expectations of what patient involvement actually is,
or perhaps the brief tool used with patients did not cap-
ture enough elements or enough similar elements that
the observer-used measures did, such as whether
benefits and harms were discussed. Patients also re-
ported low decisional conflict and high confidence in
their decision. This may reflect that the decision about
whether to use an antibiotic for a minor illness is per-
ceived by patients as a relatively simple one-off decision
with low-stake harms. A trial of a decision aid and in-
tense GP training to increase SDM for ARIs also re-
ported low decisional conflict in patients in both control
and intervention groups, with no statistically significant
between-group difference [41].
Conclusions
This study highlights that in this convenience sample of
patients with ARIs who were seeing a GP, some elements
of SDM occurred during the consultation, but that there
is need for improvements in the extent to which SDM
occurs during such consultations, including how anti-
biotic benefits and harms are discussed. Patient decision
aids may be part of the solution to improving this, but
further research about their effect and how to support
GPs to discuss antibiotic resistance with patients is
needed.
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